Cargando...
Antigenic Modulation and Rituximab Resistance
Several types of B cell lymphoma have been successfully treated with rituximab (RTX), and approval by the FDA for use of RTX in the treatment of rheumatoid arthritis has increased interest in targeting CD20 on B cells for other indications. Although large amounts of RTX can be infused into humans wi...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2010
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2848181/ https://ncbi.nlm.nih.gov/pubmed/20350659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2010.01.006 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|